If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2007 Ph.D. Graduate Institute of PharmacognosyTaipei Medical University
  • 1999 M.S., School of Pharmacy, College of Medicine, Taipei Medical University
  • 1993-1997 B.S., Department of Medical Laboratory Science and Biotechnology, Taipei Medical University

Experience

  • 2018.02- Associate Professor, Graduate Institute of Clinical Medicine, Taipei Medical University
  • 2018.02- Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University 
  • 2018.01-2014.07 Postdoctoral Researcher, Institute of Biological Chemistry, Academia Sinica
  • 2014.09-2018.01 Assistant Professor, Graduate Institute of Clinical Medicine, Taipei Medical University

Awards

  • 2015 Visiting Scholars, Genomics Research Center, Academia Sinica, Taiwan
  • 2015 Reviewer for PLoS one
  • 2008, 2009 and 2013 Reviewer for Journal of Cellular Biochemistry

Research Interests

  • Cancer Drug Discovery
  • Protein-Protein Interaction

URL

Fingerprint Dive into the research topics where Yuan-Feng Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

  • 475 Citations
  • 14 h-Index
  • 41 Article
  • Histone 2A family member j drives mesenchymal transition and temozolomide resistance in glioblastoma multiforme

    Lee, H. H., Lin, C. H., Lin, H. Y., Kuei, C. H., Zheng, J. Q., Wang, Y. H., Lu, L. S., Lee, F. P., Hu, C. J., Wu, D. & Lin, Y. F., Jan 2020, In : Cancers. 12, 1, 98.

    Research output: Contribution to journalArticle

    Open Access
  • Lactotransferrin downregulation drives the metastatic progression in clear cell renal cell carcinoma

    Chiu, I. J., Hsu, Y. H., Chang, J. S., Yang, J. C., Chiu, H. W. & Lin, Y. F., Apr 2020, In : Cancers. 12, 4, 847.

    Research output: Contribution to journalArticle

    Open Access
  • Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis

    Jan, Y. H., Lai, T. C., Yang, C. J., Lin, Y. F., Huang, M. S. & Hsiao, M., Jan 29 2019, In : Journal of Hematology and Oncology. 12, 1, 12.

    Research output: Contribution to journalArticle

  • 5 Citations (Scopus)